pharmaphorum January 24, 2025
AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as a “growing global hub” for clinical trials.
The C$820 million investment revolves around a new, larger office facility in the Greater Toronto area and will see AZ’s Canadian headcount expand “across all areas of the business,” according to a company statement.
Chief executive Pascal Soriot said the investment reflects the emergence of Canada as a hot spot for life sciences innovation, as well as AZ’s confidence in its clinical pipeline and the government’s willingness to collaborate with industry.
“We believe the diverse talent pool, together with the network of world-class universities, hospitals, and research centres, will help us bring...
Today's Sponsors
Today's Sponsor